Skip to main content

06.09.2024 | Original Article

Increased matrix stiffness in pituitary neuroendocrine tumors invading the cavernous sinus is activated by TAFs: focus on the mechanical signatures

verfasst von: Tao Xie, Yang Gao, Jiamin Hu, Rongkui Luo, Yinglong Guo, Qiang Xie, Chaolong Yan, Yifan Tang, Pin Chen, Zijiang Yang, Qinqin Yu, Fan Hu, Xiaobiao Zhang

Erschienen in: Endocrine

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Pituitary neuroendocrine tumors (PitNETs) with invasion of the cavernous sinus (CS) are particularly challenging to treat. Tumor associated fibroblasts (TAFs) are recognized for their pivotal role in reprogramming extracellular matrix (ECM). Herein, we aimed to explore the potential involvement of TAFs in ECM reprogramming and elucidate the underlying mechanism involved.

Methods

We applied dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to measure tumor vessel permeability and applied atomic force microscopy (AFM) to measure the matrix stiffness of PitNETs located in both CS and sella turcica (ST). Western blotting, immunofluorescence, immunohistochemistry, and quantitative RT-PCR were utilized to analyze the ECM components. Proteomic biochemical analysis was utilized to uncover potential mechanisms governing ECM dynamics.

Results

We found that PitNETs in the CS were stiffer than those in the ST. Increased ECM stiffness within the CS facilitated the acquisition of stem-like properties, enhanced proliferation, and induced epithelial-to-mesenchymal transition (EMT) of GH3 cells. Furthermore, the expression levels of lysyl oxidase (LOX), matrix metallopeptidase 2 (MMP2) and MMP9 in pituitary adenoma cells increased in the stiffer matrix. Proteomic analysis suggested TAFs were activated in the CS area and contributed enhanced matrix stiffness by secreting Col-1 and Col-3. Furthermore, mTOR pathway was activated under higher matrix stiffness and the migration and invasion of GH3 cells be repressed by mTOR inhibitor.

Conclusion

These findings demonstrated that activated TAFs contributed to stiffer matrix and increased ECM stiffness stimulating mTOR pathway in pituitary tumor cells. Our study indicated that mTOR inhibitor was a promising treatment strategy from the standpoint of PitNET biomechanical properties.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat G. Raverot, M.D. Ilie, H. Lasolle, V. Amodru, J. Trouillas, F. Castinetti, T. Brue, Aggressive pituitary tumours and pituitary carcinomas. Nat. Rev. Endocrinol. 17(11), 671–684 (2021)PubMedCrossRef G. Raverot, M.D. Ilie, H. Lasolle, V. Amodru, J. Trouillas, F. Castinetti, T. Brue, Aggressive pituitary tumours and pituitary carcinomas. Nat. Rev. Endocrinol. 17(11), 671–684 (2021)PubMedCrossRef
2.
Zurück zum Zitat M.D. Ilie, A. Vasiljevic, P. Bertolino, G. Raverot, Biological and therapeutic implications of the tumor microenvironment in pituitary adenomas. Endocr. Rev. 44(2), 297–311 (2023)PubMedCrossRef M.D. Ilie, A. Vasiljevic, P. Bertolino, G. Raverot, Biological and therapeutic implications of the tumor microenvironment in pituitary adenomas. Endocr. Rev. 44(2), 297–311 (2023)PubMedCrossRef
3.
Zurück zum Zitat K. Juraschka, O.H. Khan, B.L. Godoy, E. Monsalves, A. Kilian, B. Krischek, A. Ghare, A. Vescan, F. Gentili, G. Zadeh, Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection. J. Neurosurg. 121(1), 75–83 (2014)PubMedCrossRef K. Juraschka, O.H. Khan, B.L. Godoy, E. Monsalves, A. Kilian, B. Krischek, A. Ghare, A. Vescan, F. Gentili, G. Zadeh, Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection. J. Neurosurg. 121(1), 75–83 (2014)PubMedCrossRef
4.
Zurück zum Zitat S. Dhandapani, H. Singh, H.M. Negm, S. Cohen, V.K. Anand, T.H. Schwartz, Cavernous sinus invasion in pituitary adenomas: systematic review and pooled data meta-analysis of radiologic criteria and comparison of endoscopic and microscopic surgery. World Neurosurg. 96, 36–46 (2016)PubMedCrossRef S. Dhandapani, H. Singh, H.M. Negm, S. Cohen, V.K. Anand, T.H. Schwartz, Cavernous sinus invasion in pituitary adenomas: systematic review and pooled data meta-analysis of radiologic criteria and comparison of endoscopic and microscopic surgery. World Neurosurg. 96, 36–46 (2016)PubMedCrossRef
5.
6.
Zurück zum Zitat R.D. Almutairi, I.S. Muskens, D.J. Cote, M.D. Dijkman, V.K. Kavouridis, E. Crocker, K. Ghazawi, M.L.D. Broekman, T.R. Smith, R.A. Mekary, H.A. Zaidi, Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis. Acta Neurochir. (Wien.) 160(5), 1005–1021 (2018)PubMedCrossRef R.D. Almutairi, I.S. Muskens, D.J. Cote, M.D. Dijkman, V.K. Kavouridis, E. Crocker, K. Ghazawi, M.L.D. Broekman, T.R. Smith, R.A. Mekary, H.A. Zaidi, Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis. Acta Neurochir. (Wien.) 160(5), 1005–1021 (2018)PubMedCrossRef
7.
Zurück zum Zitat E. Lefevre, F. Chasseloup, M. Hage, P. Chanson, M. Buchfelder, P. Kamenicky, Clinical and therapeutic implications of cavernous sinus invasion in pituitary adenomas. Endocrine 85(3), 1058–1065 (2024)PubMedCrossRef E. Lefevre, F. Chasseloup, M. Hage, P. Chanson, M. Buchfelder, P. Kamenicky, Clinical and therapeutic implications of cavernous sinus invasion in pituitary adenomas. Endocrine 85(3), 1058–1065 (2024)PubMedCrossRef
8.
Zurück zum Zitat M. Cappelletti, A.G. Ruggeri, L. Spizzichino, A. D’Amico, E. D’Avella, R. Delfini, Fibrous pituitary macroadenomas: Predictive role of preoperative radiologic investigations for proper surgical planning in a cohort of 66 patients. World Neurosurg. 121, e449–e457 (2019)PubMedCrossRef M. Cappelletti, A.G. Ruggeri, L. Spizzichino, A. D’Amico, E. D’Avella, R. Delfini, Fibrous pituitary macroadenomas: Predictive role of preoperative radiologic investigations for proper surgical planning in a cohort of 66 patients. World Neurosurg. 121, e449–e457 (2019)PubMedCrossRef
9.
Zurück zum Zitat C. Li, H. Zhu, X. Zong, X. Wang, S. Gui, P. Zhao, J. Bai, C. Liu, L. Cao, Z. Li, Y. Zhang, Experience of trans-nasal endoscopic surgery for pituitary tumors in a single center in China: Surgical results in a cohort of 2032 patients, operated between 2006 and 2018. Clin. Neurol. Neurosurg. 197, 106176 (2020)PubMedCrossRef C. Li, H. Zhu, X. Zong, X. Wang, S. Gui, P. Zhao, J. Bai, C. Liu, L. Cao, Z. Li, Y. Zhang, Experience of trans-nasal endoscopic surgery for pituitary tumors in a single center in China: Surgical results in a cohort of 2032 patients, operated between 2006 and 2018. Clin. Neurol. Neurosurg. 197, 106176 (2020)PubMedCrossRef
10.
Zurück zum Zitat P. Li, D. Zhang, S. Ma, P. Kang, C. Zhang, B. Mao, W. Zhou, X. Wang, J. Peng, L. Yuan, Y. Wang, J. Diao, W. Jia, Consistency of pituitary adenomas: Amounts of collagen types I and III and the predictive value of T2WI MRI. Exp. Ther. Med. 22(5), 1255 (2021)PubMedPubMedCentralCrossRef P. Li, D. Zhang, S. Ma, P. Kang, C. Zhang, B. Mao, W. Zhou, X. Wang, J. Peng, L. Yuan, Y. Wang, J. Diao, W. Jia, Consistency of pituitary adenomas: Amounts of collagen types I and III and the predictive value of T2WI MRI. Exp. Ther. Med. 22(5), 1255 (2021)PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat A. Acitores Cancela, V. Rodriguez Berrocal, H. Pian Arias, J.J. Diez, P. Iglesias, Effect of pituitary adenoma consistency on surgical outcomes in patients undergoing endonasal endoscopic transsphenoidal surgery. Endocrine 78(3), 559–569 (2022)PubMedCrossRef A. Acitores Cancela, V. Rodriguez Berrocal, H. Pian Arias, J.J. Diez, P. Iglesias, Effect of pituitary adenoma consistency on surgical outcomes in patients undergoing endonasal endoscopic transsphenoidal surgery. Endocrine 78(3), 559–569 (2022)PubMedCrossRef
12.
Zurück zum Zitat M.D. Ilie, D. De Alcubierre, A.L. Carretti, E. Jouanneau, G. Raverot, Therapeutic targeting of the pituitary tumor microenvironment. Pharm. Ther. 250, 108506 (2023)CrossRef M.D. Ilie, D. De Alcubierre, A.L. Carretti, E. Jouanneau, G. Raverot, Therapeutic targeting of the pituitary tumor microenvironment. Pharm. Ther. 250, 108506 (2023)CrossRef
13.
Zurück zum Zitat Z. Yang, X. Tian, K. Yao, Y. Yang, L. Zhang, N. Liu, C. Yan, X. Qi, S. Han, Targeting the tumor immune microenvironment could become a potential therapeutic modality for aggressive pituitary adenoma. Brain Sci. 13(2), 164 (2023)PubMedPubMedCentralCrossRef Z. Yang, X. Tian, K. Yao, Y. Yang, L. Zhang, N. Liu, C. Yan, X. Qi, S. Han, Targeting the tumor immune microenvironment could become a potential therapeutic modality for aggressive pituitary adenoma. Brain Sci. 13(2), 164 (2023)PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat M. Kalli, M.D. Poskus, T. Stylianopoulos, I.K. Zervantonakis, Beyond matrix stiffness: targeting force-induced cancer drug resistance. Trends Cancer 9(11), 937–954 (2023)PubMedPubMedCentralCrossRef M. Kalli, M.D. Poskus, T. Stylianopoulos, I.K. Zervantonakis, Beyond matrix stiffness: targeting force-induced cancer drug resistance. Trends Cancer 9(11), 937–954 (2023)PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat A. Saraswathibhatla, D. Indana, O. Chaudhuri, Cell-extracellular matrix mechanotransduction in 3D. Nat. Rev. Mol. Cell Biol. 24(7), 495–516 (2023)PubMedPubMedCentralCrossRef A. Saraswathibhatla, D. Indana, O. Chaudhuri, Cell-extracellular matrix mechanotransduction in 3D. Nat. Rev. Mol. Cell Biol. 24(7), 495–516 (2023)PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Y. Tang, T. Xie, S. Wu, Q. Yang, T. Liu, C. Li, S. Liu, Z. Shao, X. Zhang, Quantitative proteomics revealed the molecular characteristics of distinct types of granulated somatotroph adenomas. Endocrine 74(2), 375–386 (2021)PubMedCrossRef Y. Tang, T. Xie, S. Wu, Q. Yang, T. Liu, C. Li, S. Liu, Z. Shao, X. Zhang, Quantitative proteomics revealed the molecular characteristics of distinct types of granulated somatotroph adenomas. Endocrine 74(2), 375–386 (2021)PubMedCrossRef
17.
Zurück zum Zitat Z. Wang, M. Chang, Y. Zhang, G. Zhou, P. Liu, J. Lou, Y. Wang, Y. Zhang, X. Guo, Y. Wang, X. Bao, W. Lian, Y. Wang, R. Wang, W. Ma, B. Xing, J. Gao, Multi-omics investigations revealed underlying molecular mechanisms associated with tumor stiffness and identified sunitinib as a potential therapy for reducing stiffness in pituitary adenomas. Front Cell Dev. Biol. 10, 820562 (2022)PubMedPubMedCentralCrossRef Z. Wang, M. Chang, Y. Zhang, G. Zhou, P. Liu, J. Lou, Y. Wang, Y. Zhang, X. Guo, Y. Wang, X. Bao, W. Lian, Y. Wang, R. Wang, W. Ma, B. Xing, J. Gao, Multi-omics investigations revealed underlying molecular mechanisms associated with tumor stiffness and identified sunitinib as a potential therapy for reducing stiffness in pituitary adenomas. Front Cell Dev. Biol. 10, 820562 (2022)PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat O.M. Mahmoud, A. Tominaga, V.J. Amatya, M. Ohtaki, K. Sugiyama, T. Sakoguchi, Y. Kinoshita, Y. Takeshima, N. Abe, Y. Akiyama, A.I. El-Ghoriany, A.K. Abd Alla, M.A. El-Sharkawy, K. Arita, K. Kurisu, F. Yamasaki, Role of PROPELLER diffusion-weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas. Eur. J. Radio. 80(2), 412–417 (2011)CrossRef O.M. Mahmoud, A. Tominaga, V.J. Amatya, M. Ohtaki, K. Sugiyama, T. Sakoguchi, Y. Kinoshita, Y. Takeshima, N. Abe, Y. Akiyama, A.I. El-Ghoriany, A.K. Abd Alla, M.A. El-Sharkawy, K. Arita, K. Kurisu, F. Yamasaki, Role of PROPELLER diffusion-weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas. Eur. J. Radio. 80(2), 412–417 (2011)CrossRef
19.
Zurück zum Zitat Y.Q. Liu, B.B. Gao, B. Dong, S.S. Padikkalakandy Cheriyath, Q.W. Song, B. Xu, Q. Wei, L.Z. Xie, Y. Guo, Y.W. Miao, Preoperative vascular heterogeneity and aggressiveness assessment of pituitary macroadenoma based on dynamic contrast-enhanced MRI texture analysis. Eur. J. Radiol. 129, 109125 (2020)PubMedCrossRef Y.Q. Liu, B.B. Gao, B. Dong, S.S. Padikkalakandy Cheriyath, Q.W. Song, B. Xu, Q. Wei, L.Z. Xie, Y. Guo, Y.W. Miao, Preoperative vascular heterogeneity and aggressiveness assessment of pituitary macroadenoma based on dynamic contrast-enhanced MRI texture analysis. Eur. J. Radiol. 129, 109125 (2020)PubMedCrossRef
20.
Zurück zum Zitat Y. Wang, R. Luo, X. Zhang, H. Xiang, B. Yang, J. Feng, M. Deng, P. Ran, A. Sujie, F. Zhang, J. Zhu, S. Tan, T. Xie, P. Chen, Z. Yu, Y. Li, D. Jiang, X. Zhang, J.Y. Zhao, Y. Hou, C. Ding, Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms. Nat. Commun. 14(1), 505 (2023)PubMedPubMedCentralCrossRef Y. Wang, R. Luo, X. Zhang, H. Xiang, B. Yang, J. Feng, M. Deng, P. Ran, A. Sujie, F. Zhang, J. Zhu, S. Tan, T. Xie, P. Chen, Z. Yu, Y. Li, D. Jiang, X. Zhang, J.Y. Zhao, Y. Hou, C. Ding, Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms. Nat. Commun. 14(1), 505 (2023)PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat L. Lv, S. Zhang, Y. Hu, P. Zhou, L. Gao, M. Wang, Z. Sun, C. Chen, S. Yin, X. Wang, S. Jiang, Invasive pituitary adenoma-derived tumor-associated fibroblasts promote tumor progression both in vitro and in vivo. Exp. Clin. Endocrinol. Diab 126(4), 213–221 (2018)CrossRef L. Lv, S. Zhang, Y. Hu, P. Zhou, L. Gao, M. Wang, Z. Sun, C. Chen, S. Yin, X. Wang, S. Jiang, Invasive pituitary adenoma-derived tumor-associated fibroblasts promote tumor progression both in vitro and in vivo. Exp. Clin. Endocrinol. Diab 126(4), 213–221 (2018)CrossRef
22.
Zurück zum Zitat P. Marques, S. Barry, E. Carlsen, D. Collier, A. Ronaldson, S. Awad, N. Dorward, J. Grieve, N. Mendoza, S. Muquit, A.B. Grossman, F. Balkwill, M. Korbonits, Pituitary tumour fibroblast-derived cytokines influence tumour aggressiveness. Endocr. Relat. Cancer 26(12), 853–865 (2019)PubMedCrossRef P. Marques, S. Barry, E. Carlsen, D. Collier, A. Ronaldson, S. Awad, N. Dorward, J. Grieve, N. Mendoza, S. Muquit, A.B. Grossman, F. Balkwill, M. Korbonits, Pituitary tumour fibroblast-derived cytokines influence tumour aggressiveness. Endocr. Relat. Cancer 26(12), 853–865 (2019)PubMedCrossRef
23.
Zurück zum Zitat T. Martinello, F. Pascoli, G. Caporale, A. Perazzi, I. Iacopetti, M. Patruno, Might the Masson trichrome stain be considered a useful method for categorizing experimental tendon lesions? Histol. Histopathol. 30(8), 963–9 (2015)PubMed T. Martinello, F. Pascoli, G. Caporale, A. Perazzi, I. Iacopetti, M. Patruno, Might the Masson trichrome stain be considered a useful method for categorizing experimental tendon lesions? Histol. Histopathol. 30(8), 963–9 (2015)PubMed
24.
Zurück zum Zitat M. Xia, M. Wu, Y. Li, Y. Liu, G. Jia, Y. Lou, J. Ma, Q. Gao, M. Xie, Y. Chen, Y. He, H. Li, W. Li, Varying mechanical forces drive sensory epithelium formation. Sci. Adv. 9(44), eadf2664 (2023). M. Xia, M. Wu, Y. Li, Y. Liu, G. Jia, Y. Lou, J. Ma, Q. Gao, M. Xie, Y. Chen, Y. He, H. Li, W. Li, Varying mechanical forces drive sensory epithelium formation. Sci. Adv. 9(44), eadf2664 (2023).
25.
Zurück zum Zitat M. Nurmik, P. Ullmann, F. Rodriguez, S. Haan, E. Letellier, In search of definitions: Cancer-associated fibroblasts and their markers. Int. J. Cancer 146(4), 895–905 (2020)PubMedCrossRef M. Nurmik, P. Ullmann, F. Rodriguez, S. Haan, E. Letellier, In search of definitions: Cancer-associated fibroblasts and their markers. Int. J. Cancer 146(4), 895–905 (2020)PubMedCrossRef
26.
Zurück zum Zitat A.N. Gargalionis, K.A. Papavassiliou, E.K. Basdra, A.G. Papavassiliou, mTOR signaling components in tumor mechanobiology. Int. J. Mol. Sci. 23(3), 1825 (2022)PubMedPubMedCentralCrossRef A.N. Gargalionis, K.A. Papavassiliou, E.K. Basdra, A.G. Papavassiliou, mTOR signaling components in tumor mechanobiology. Int. J. Mol. Sci. 23(3), 1825 (2022)PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Y. You, Q. Zheng, Y. Dong, X. Xie, Y. Wang, S. Wu, L. Zhang, Y. Wang, T. Xue, Z. Wang, R. Chen, Y. Wang, J. Cui, Z. Ren, Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells. Oncotarget 7(22), 32221–32231 (2016)PubMedPubMedCentralCrossRef Y. You, Q. Zheng, Y. Dong, X. Xie, Y. Wang, S. Wu, L. Zhang, Y. Wang, T. Xue, Z. Wang, R. Chen, Y. Wang, J. Cui, Z. Ren, Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells. Oncotarget 7(22), 32221–32231 (2016)PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat T. Nandi, S.R.K. Ainavarapu, Applications of atomic force microscopy in modern biology. Emerg. Top. Life Sci. 5(1), 103–111 (2021)CrossRef T. Nandi, S.R.K. Ainavarapu, Applications of atomic force microscopy in modern biology. Emerg. Top. Life Sci. 5(1), 103–111 (2021)CrossRef
29.
Zurück zum Zitat X. Wei, H. Lou, D. Zhou, Y. Jia, H. Li, Q. Huang, J. Ma, Z. Yang, C. Sun, Y. Meng, S. Xu, X. Yang, X. Li, T. Ji, Z. Guo, Q. Gao, TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK. Pathw. J. Exp. Clin. Cancer Res. 40(1), 292 (2021)CrossRef X. Wei, H. Lou, D. Zhou, Y. Jia, H. Li, Q. Huang, J. Ma, Z. Yang, C. Sun, Y. Meng, S. Xu, X. Yang, X. Li, T. Ji, Z. Guo, Q. Gao, TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK. Pathw. J. Exp. Clin. Cancer Res. 40(1), 292 (2021)CrossRef
30.
Zurück zum Zitat J. Najera, M.R. Rosenberger, M. Datta, Atomic force microscopy methods to measure tumor mechanical properties. Cancers (Basel) 15(13), 3285 (2023)PubMedCrossRef J. Najera, M.R. Rosenberger, M. Datta, Atomic force microscopy methods to measure tumor mechanical properties. Cancers (Basel) 15(13), 3285 (2023)PubMedCrossRef
31.
Zurück zum Zitat Y. Shen, X. Wang, J. Lu, M. Salfenmoser, N.M. Wirsik, N. Schleussner, A. Imle, A. Freire Valls, P. Radhakrishnan, J. Liang, G. Wang, T. Muley, M. Schneider, C. Ruiz de Almodovar, A. Diz-Munoz, T. Schmidt, Reduction of liver metastasis stiffness improves response to bevacizumab in metastatic colorectal cancer. Cancer Cell 37(6), 800–817 (2020)PubMedCrossRef Y. Shen, X. Wang, J. Lu, M. Salfenmoser, N.M. Wirsik, N. Schleussner, A. Imle, A. Freire Valls, P. Radhakrishnan, J. Liang, G. Wang, T. Muley, M. Schneider, C. Ruiz de Almodovar, A. Diz-Munoz, T. Schmidt, Reduction of liver metastasis stiffness improves response to bevacizumab in metastatic colorectal cancer. Cancer Cell 37(6), 800–817 (2020)PubMedCrossRef
32.
33.
Zurück zum Zitat P. Marques, M. Korbonits, Tumour microenvironment and pituitary tumour behaviour. J. Endocrinol. Invest 46(6), 1047–1063 (2023)PubMedCrossRef P. Marques, M. Korbonits, Tumour microenvironment and pituitary tumour behaviour. J. Endocrinol. Invest 46(6), 1047–1063 (2023)PubMedCrossRef
34.
Zurück zum Zitat H.Y. Liu, W.J. Gu, C.Z. Wang, X.J. Ji, Y.M. Mu, Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas: A systematic review and meta-analysis of case-control trials. Med. (Baltim.) 95(24), e3904 (2016)CrossRef H.Y. Liu, W.J. Gu, C.Z. Wang, X.J. Ji, Y.M. Mu, Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas: A systematic review and meta-analysis of case-control trials. Med. (Baltim.) 95(24), e3904 (2016)CrossRef
35.
Zurück zum Zitat S. Wu, Q. Zheng, X. Xing, Y. Dong, Y. Wang, Y. You, R. Chen, C. Hu, J. Chen, D. Gao, Y. Zhao, Z. Wang, T. Xue, Z. Ren, J. Cui, Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation. J. Exp. Clin. Cancer Res 37(1), 99 (2018)PubMedPubMedCentralCrossRef S. Wu, Q. Zheng, X. Xing, Y. Dong, Y. Wang, Y. You, R. Chen, C. Hu, J. Chen, D. Gao, Y. Zhao, Z. Wang, T. Xue, Z. Ren, J. Cui, Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation. J. Exp. Clin. Cancer Res 37(1), 99 (2018)PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat P. Marques, A.B. Grossman, M. Korbonits, The tumour microenvironment of pituitary neuroendocrine tumours. Front Neuroendocrinol. 58, 100852 (2020)PubMedCrossRef P. Marques, A.B. Grossman, M. Korbonits, The tumour microenvironment of pituitary neuroendocrine tumours. Front Neuroendocrinol. 58, 100852 (2020)PubMedCrossRef
37.
Zurück zum Zitat M. Lopez-Cavestany, S.B. Hahn, J.M. Hope, N.T. Reckhorn, J.D. Greenlee, S.C. Schwager, J.A. VanderBurgh, C.A. Reinhart-King, M.R. King, Matrix stiffness induces epithelial-to-mesenchymal transition via Piezo1-regulated calcium flux in prostate cancer cells. iScience 26(4), 106275 (2023)PubMedPubMedCentralCrossRef M. Lopez-Cavestany, S.B. Hahn, J.M. Hope, N.T. Reckhorn, J.D. Greenlee, S.C. Schwager, J.A. VanderBurgh, C.A. Reinhart-King, M.R. King, Matrix stiffness induces epithelial-to-mesenchymal transition via Piezo1-regulated calcium flux in prostate cancer cells. iScience 26(4), 106275 (2023)PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Y. Dong, Q. Zheng, Z. Wang, X. Lin, Y. You, S. Wu, Y. Wang, C. Hu, X. Xie, J. Chen, D. Gao, Y. Zhao, W. Wu, Y. Liu, Z. Ren, R. Chen, J. Cui, Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis. J. Hematol. Oncol. 12(1), 112 (2019)PubMedPubMedCentralCrossRef Y. Dong, Q. Zheng, Z. Wang, X. Lin, Y. You, S. Wu, Y. Wang, C. Hu, X. Xie, J. Chen, D. Gao, Y. Zhao, W. Wu, Y. Liu, Z. Ren, R. Chen, J. Cui, Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis. J. Hematol. Oncol. 12(1), 112 (2019)PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Y.X. Liu, S. Wan, X.Q. Yang, Y. Wang, W.J. Gan, W.L. Ye, X.S. He, J.J. Chen, Y. Yang, X.M. Yang, X. Guo, X.J. Gao, Y.T. Lu, Z.Y. Deng, G. Hu, H. Wu, TRIM21 is a druggable target for the treatment of metastatic colorectal cancer through ubiquitination and activation of MST2. Cell Chem. Biol. 30(7), 709–725 (2023)PubMedCrossRef Y.X. Liu, S. Wan, X.Q. Yang, Y. Wang, W.J. Gan, W.L. Ye, X.S. He, J.J. Chen, Y. Yang, X.M. Yang, X. Guo, X.J. Gao, Y.T. Lu, Z.Y. Deng, G. Hu, H. Wu, TRIM21 is a druggable target for the treatment of metastatic colorectal cancer through ubiquitination and activation of MST2. Cell Chem. Biol. 30(7), 709–725 (2023)PubMedCrossRef
40.
Zurück zum Zitat E. Marhuenda, C. Fabre, C. Zhang, M. Martin-Fernandez, T. Iskratsch, A. Saleh, L. Bauchet, J. Cambedouzou, J.P. Hugnot, H. Duffau, J.W. Dennis, D. Cornu, N. Bakalara, Glioma stem cells invasive phenotype at optimal stiffness is driven by MGAT5 dependent mechanosensing. J. Exp. Clin. Cancer Res. 40(1), 139 (2021)PubMedPubMedCentralCrossRef E. Marhuenda, C. Fabre, C. Zhang, M. Martin-Fernandez, T. Iskratsch, A. Saleh, L. Bauchet, J. Cambedouzou, J.P. Hugnot, H. Duffau, J.W. Dennis, D. Cornu, N. Bakalara, Glioma stem cells invasive phenotype at optimal stiffness is driven by MGAT5 dependent mechanosensing. J. Exp. Clin. Cancer Res. 40(1), 139 (2021)PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat M. Di-Luoffo, Z. Ben-Meriem, P. Lefebvre, M. Delarue, J. Guillermet-Guibert, PI3K functions as a hub in mechanotransduction. Trends Biochem Sci. 46(11), 878–888 (2021)PubMedCrossRef M. Di-Luoffo, Z. Ben-Meriem, P. Lefebvre, M. Delarue, J. Guillermet-Guibert, PI3K functions as a hub in mechanotransduction. Trends Biochem Sci. 46(11), 878–888 (2021)PubMedCrossRef
42.
Zurück zum Zitat J. Pawlonka, B. Rak, U. Ambroziak, The regulation of cyclin D promoters - review. Cancer Treat. Res. Commun. 27, 100338 (2021)PubMedCrossRef J. Pawlonka, B. Rak, U. Ambroziak, The regulation of cyclin D promoters - review. Cancer Treat. Res. Commun. 27, 100338 (2021)PubMedCrossRef
43.
Zurück zum Zitat M.J. Duffy, S. O’Grady, M. Tang, J. Crown, MYC as a target for cancer treatment. Cancer Treat. Rev. 94, 102154 (2021)PubMedCrossRef M.J. Duffy, S. O’Grady, M. Tang, J. Crown, MYC as a target for cancer treatment. Cancer Treat. Rev. 94, 102154 (2021)PubMedCrossRef
44.
Zurück zum Zitat S. Banjara, C.D. Suraweera, M.G. Hinds, M. Kvansakul, The Bcl-2 family: Ancient origins, conserved structures, and divergent mechanisms. Biomolecules 10(1), 128 (2020)PubMedPubMedCentralCrossRef S. Banjara, C.D. Suraweera, M.G. Hinds, M. Kvansakul, The Bcl-2 family: Ancient origins, conserved structures, and divergent mechanisms. Biomolecules 10(1), 128 (2020)PubMedPubMedCentralCrossRef
Metadaten
Titel
Increased matrix stiffness in pituitary neuroendocrine tumors invading the cavernous sinus is activated by TAFs: focus on the mechanical signatures
verfasst von
Tao Xie
Yang Gao
Jiamin Hu
Rongkui Luo
Yinglong Guo
Qiang Xie
Chaolong Yan
Yifan Tang
Pin Chen
Zijiang Yang
Qinqin Yu
Fan Hu
Xiaobiao Zhang
Publikationsdatum
06.09.2024
Verlag
Springer US
Erschienen in
Endocrine
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-024-04022-9

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Duale Checkpointhemmung gegen Melanome verlängert langfristig das Leben

Im Vergleich zu den Überlebenschancen vor der Einführung von Immuncheckpointhemmern (ICI) ist der Fortschritt durch eine ICI-Kombination mit unterschiedlichen Tagets bei fortgeschrittenem Melanom erstaunlich. Das belegen die finalen Ergebnisse der CheckMate-067-Studie und geben Betroffenen "Hoffnung auf Heilung".

Knochenmarktransplantat als Chance für ältere AML-Patienten

Lange Zeit ist die Transplantation von hämatopoetischen Stammzellen nur bei jüngeren Patienten mit akuter myeloischer Leukämie praktiziert worden. Inzwischen profitieren auch Ältere davon. Ergebnisse einer Studie unterstützen dieses Vorgehen.

Nierenzellkarzinom: Kein Nachteil durch subkutan appliziertes Nivolumab

Die subkutane Applikation von Nivolumab ist nach Daten einer Phase-3-Studie ähnlich gut wirksam wie die intravenöse: Die Pharmakokinetik ist vergleichbar, die objektive Response war in der Studie sogar leicht besser als in der Gruppe mit Infusionen.

Vorteile für Androgenentzug plus Androgenrezeptorblockade

Für Männer mit metastasiertem hormonsensitivem Prostata-Ca. (mHSPC), die keine Hormonchemotherapie wollen oder vertragen, ist der Androgenentzug plus Darolutamid eine Alternative: Das Progressionsrisiko wird im Vergleich zum alleinigen Androgenentzug fast halbiert.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.